These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12882808)

  • 1. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
    Bourges JL; Gautier SE; Delie F; Bejjani RA; Jeanny JC; Gurny R; BenEzra D; Behar-Cohen FF
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3562-9. PubMed ID: 12882808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
    Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K
    Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for gene delivery to retinal pigment epithelial cells.
    Bejjani RA; BenEzra D; Cohen H; Rieger J; Andrieu C; Jeanny JC; Gollomb G; Behar-Cohen FF
    Mol Vis; 2005 Feb; 11():124-32. PubMed ID: 15735602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
    Mol Vis; 2007 Dec; 13():2263-74. PubMed ID: 18451986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable Nanoparticles Based on Pseudo-Proteins Show Promise as Carriers for Ophthalmic Drug Delivery.
    Zhang W; Kantaria T; Zhang Y; Kantaria T; Kobauri S; Tugushi D; Brücher V; Katsarava R; Eter N; Heiduschka P
    J Ocul Pharmacol Ther; 2020; 36(6):421-432. PubMed ID: 32639222
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
    Kim H; Robinson SB; Csaky KG
    Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
    Gan L; Wang J; Zhao Y; Chen D; Zhu C; Liu J; Gan Y
    Biomaterials; 2013 Aug; 34(24):5978-87. PubMed ID: 23680367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats.
    Sakai T; Kuno N; Takamatsu F; Kimura E; Kohno H; Okano K; Kitahara K
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3381-7. PubMed ID: 17591912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium.
    Ogura Y; Kimura H
    Surv Ophthalmol; 1995 May; 39 Suppl 1():S17-24. PubMed ID: 7660308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
    Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
    Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release.
    Kimura H; Ogura Y; Moritera T; Honda Y; Tabata Y; Ikada Y
    Curr Eye Res; 1994 May; 13(5):353-60. PubMed ID: 8055699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis.
    Valamanesh F; Torriglia A; Savoldelli M; Gandolphe C; Jeanny JC; BenEzra D; Behar-Cohen F
    Mol Vis; 2007 Sep; 13():1746-57. PubMed ID: 17960113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eye pigmentation on transscleral drug delivery.
    Cheruvu NP; Amrite AC; Kompella UB
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
    Ophthalmic Res; 2008; 40(3-4):145-50. PubMed ID: 18421229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical localization of gentamicin in the rabbit retina following intravitreal injection.
    Tabatabay CA; Young LH; D'Amico DJ; Kenyon KR
    Arch Ophthalmol; 1990 May; 108(5):723-6. PubMed ID: 2185724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially cleaving peptides as a strategy for controlled drug release in human retinal pigment epithelial cells.
    Bhattacharya M; Sarkhel S; Peltoniemi J; Broadbridge R; Tuomainen M; Auriola S; Urtti A
    J Control Release; 2017 Apr; 251():37-48. PubMed ID: 28213274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of superparamagnetic microbeads in tracking subretinal injections.
    Wen J; McKenna KC; Barron BC; Langston HP; Kapp JA
    Mol Vis; 2005 Apr; 11():256-62. PubMed ID: 15851980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
    Tzameret A; Ketter-Katz H; Edelshtain V; Sher I; Corem-Salkmon E; Levy I; Last D; Guez D; Mardor Y; Margel S; Rotenstrich Y
    J Nanobiotechnology; 2019 Jan; 17(1):3. PubMed ID: 30630490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice.
    Kim TW; Lindsey JD; Aihara M; Anthony TL; Weinreb RN
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1809-16. PubMed ID: 12036983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.